Search

everythinglearnresearchcommunity

for

Search:↓

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.

Immune cells and plasma proteins are linked to hair loss, suggesting new treatment options.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Early regulatory T cells are crucial for normal skin pigmentation.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

γδ T cells adapt uniquely to different tissues in mice.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

Six key genes can predict bladder cancer outcomes and may serve as prognostic biomarkers.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Keloid skin disorder involves abnormal fibroblast activation and immune response, linked to a group of genes including FGF11.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

The new vaccine platform led to a stronger immune response and better protection against the flu than the traditional vaccine.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Deleting the BRD4 protein in certain skin cells causes hair loss and skin inflammation.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

A man with skin and hair symptoms improved partially with specific treatment.

Chronic contact eczema may help hair regrowth in alopecia areata by reducing certain immune cell movement.

New therapies are being developed that target integrin pathways to treat various diseases.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Heat treatment increases hair loss in certain mice.

Cyclosporine effectively treated a woman's stubborn skin condition.

Gasdermin A3 overexpression in skin causes inflammation and hair loss.

A man with a type of skin lymphoma had unusual yellowish skin growths despite normal blood lipid levels, and treatment reduced some symptoms but not the growths.

Gut microbiota influences the development of alopecia areata.